Adopting orphan drugs: Congress tries to encourage new remedies for rare diseases
- PMID: 10317248
Item in Clipboard
Adopting orphan drugs: Congress tries to encourage new remedies for rare diseases
Time.
.
No abstract available
Similar articles
-
New drug development in the changing health care environment: a panel discussion.Ann N Y Acad Sci. 1981;368:203-11. Ann N Y Acad Sci. 1981. PMID: 6942776 No abstract available.
-
Development of orphan products.FDA Drug Bull. 1983 Apr;13(1):2-4. FDA Drug Bull. 1983. PMID: 6852406 No abstract available.
-
Orphan Drug Act on congressional agenda.Physician Exec. 1989 May-Jun;15(3):34-5. Physician Exec. 1989. PMID: 10313123
-
Orphan drugs: the question of products liability.Am J Law Med. 1985 Winter;10(4):491-513. Am J Law Med. 1985. PMID: 3911776 Review.
-
Fake pharmaceuticals: how they and relevant legislation or lack thereof contribute to consistently high and increasing drug prices.Am J Law Med. 2003;29(4):525-42. Am J Law Med. 2003. PMID: 15119247 Review. No abstract available.
Cited by
-
Identification of strengths and weaknesses of the healthcare system for persons living with rare diseases in Catalonia (Spain), and recommendations to improve its comprehensive attention: the "acERca las enfermedades raras" project.Orphanet J Rare Dis. 2025 Jan 29;20(1):42. doi: 10.1186/s13023-024-03518-x. Orphanet J Rare Dis. 2025. PMID: 39875900 Free PMC article.